Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

RECOVER:Comparison of Renal Toxicity Between Visipaque(Iodixanol)and Hexabrix(Ioxaglate)in Renal Insufficiency Undergoing Coronary Angiography

This study has been completed.
Information provided by:
Seoul National University Hospital Identifier:
First received: October 31, 2005
Last updated: November 29, 2006
Last verified: January 2005